AAV Vectors in Gene Therapy Pipeline Landscape Report 2024: Comprehensive Insights about 70+ Companies and 235+ Pipeline Drugs
April 19, 2024 07:31 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "AAV vectors in gene therapy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "AAV vectors in gene...
Global Optogenetics Market Report 2024-2033: Emerging Trends in Tools & Technologies, Pharma Collaborations, Drug Discovery & Development Integration, and Non-Neural Cell Type Applications
January 18, 2024 06:53 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Optogenetics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global optogenetics market has grown rapidly in...
Global Optogenetics Market Assessment 2018-2023 and Forecast 2024-2028, Featuring Key Players Hubner Group (Cobolt Inc.), Coherent Inc., and Gensight Biologics SA Among Others
January 11, 2024 11:53 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Optogenetics Market Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's offering. ...
Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience
June 22, 2023 03:00 ET
|
Institute of Molecular and Clinical Ophthalmology Basel (IOB)
Basel, Switzerland, June 22, 2023 --In recognition of their pioneering work on restoring vision to blind patients using optogenetic therapy, Botond Roska and José-Alain Sahel were today awarded the...
Global Optogenetics Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
April 13, 2022 07:48 ET
|
Research and Markets
Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Optogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Foundation Fighting Blindness and RetroSense Therapeutics Make Progress Toward First-Ever Clinical Trial for Optogenetic Gene Therapy Treatment
May 25, 2012 08:58 ET
|
Foundation Fighting Blindness
OWINGS MILLS, Md., May 25, 2012 (GLOBE NEWSWIRE) -- After a productive meeting this week with the U.S. Food and Drug Administration (FDA), the Foundation Fighting Blindness acknowledges a clearer path...